PCNA and benign prostatic hyperplasia: Western blot analysis showed that, compared with the NC group, the levels of PCNA and cyclin D1 protein were markedly higher in the TP-induced BPH group and markedly reduced in the YSTE-treated groups and the finasteride-treated group (Figure 4(a)).